Detection of tumor cells in body cavity fluids by flow cytometric and immunocytochemical analysis.
Measurement of electronic volume versus DNA content of nuclei can be used to discriminate between normal and malignant cells. Epithelial membrane antigen immunocytochemistry (EMA-ICC), a helpful ancillary test in body cavity fluids, is not universally accurate for detecting malignancy in effusions. The current study was undertaken to determine if multiparametric flow cytometry (based on simultaneous analysis of light scatter, nuclear volume, DNA, and nuclear protein content) in combination with (EMA-ICC) could be used for the detection of malignant cells in peritoneal and pleural fluids. We studied 130 body cavity fluids (68 peritoneal and 62 pleural fluids) by conventional cytology and multiparametric laser flow cytometry. EMA-ICC was performed using EMA antibodies and L-SAB detection system (DakoCytomation, Carpinteria, CA). EMA-ICC had significantly higher sensitivity than conventional cytology (79% versus 59%, P = 0.016) and ploidy (79% versus 38%, P = 0.001). Cytology had significantly higher specificity than ploidy (97% versus 82%, P = 0.012). The differences in specificity between EMA-ICC and ploidy (87% versus 82%, P= 0.607) or EMA-ICC and cytology (87% versus 97%, P = 0.109) were not statistically significant. However, assuming serial testing, sensitivity increased significantly for the combinations of cytology and EMA-ICC (79.4%, P = 0.016) and cytology and ploidy (73.5%, P = 0.004) as compared to cytology alone (58.8%). Also, the combination of cytology and ploidy had a higher sensitivity than ploidy alone (73% versus 38%, P < 0.0001). However, the sensitivity associated with the three tests used in serial (85.3%) was not significantly different from the sensitivities corresponding to the combination of cytology and EMA-ICC (79%) or cytology and ploidy (73%). Multiparametric flow cytometry utilizing high resolution DNA, nuclear volume, protein measurement, and ICC, in combination with cytomorphology, may be a valuable tool for rapid identification of malignant cells in body cavity fluids.
Krishan
Awtar
A
Department of Pathology, University of Miami Miller School of Medicine, Miami, Florida 33101, USA. akrishnan@med.maimi.edu
Ganjei-Azar
Parvin
P
Jorda
Merce
M
Hamelik
Ronald M
RM
Reis
Isildinha M
IM
Nadji
Mehrdad
M
D000782:Aneuploidy; D001202:Ascitic Fluid / Q000737:chemistry*; D004273:DNA, Neoplasm / Q000032:analysis; D003937:Diagnosis, Differential; D004848:Epithelium / Q000737:chemistry; D005240:Feasibility Studies; D005434:Flow Cytometry / Q000379:methods*; D006801:Humans; D007150:Immunohistochemistry; D008103:Liver Cirrhosis / Q000378:metabolism / Q000473:pathology; D018396:Mucin-1 / Q000032:analysis*; D009369:Neoplasms / Q000175:diagnosis*; D010996:Pleural Effusion / Q000737:chemistry*; D011237:Predictive Value of Tests
D004273:DNA, Neoplasm; D018396:Mucin-1